What this university is, in practice
Bangor and Liverpool John Moores charge exactly the same fee, £21,000, and sit in cities this site prices identically at €10,700 a year. On every number available they are the same decision. The difference is evidence: Liverpool John Moores has confirmed its 2026-2027 fee and Bangor has not — Bangor is the only unconfirmed price among the nineteen UK MPharm pages here.
The same price, differently evidenced
The most recently published figure is £21,000 per academic year, about €24,282 at the ECB planning rate this site uses. It comes from the 2025-2026 cycle as a fallback, and our record notes the 2026-2027 course-specific fee remains unconfirmed on the course page. It is carried as an official prior-year figure for planning until the university publishes a newer one.
Liverpool John Moores publishes the identical £21,000 and has confirmed it for 2026-2027. Both cities cost about €10,700 a year on this site's presets — Bangor rated Medium confidence, Liverpool High. Four years works out at roughly €97,100 in tuition and €139,900 all in at either.
So this is the cleanest illustration in the whole catalog of what confirmation status actually means. Two identical numbers, one of which you can plan against and one of which you cannot. Bangor's may well be reconfirmed at £21,000; it may not. The honest position is that a fee carried forward from a prior cycle is a starting point, and the school should be asked for the current figure in writing before it decides anything.
The highest English requirement in this block
Bangor asks for IELTS 7.0 overall with at least 6.5 in every subskill. Across the pharmacy schools profiled in this pass, that is the highest overall band recorded, and the subskill floor makes it stricter than a bare 7.0.
Ulster, profiled alongside it today, asks 6.5 overall with 6.5 in speaking and nothing below 6.0. Those two rules fail different candidates: someone with an even 6.8 profile clears Ulster and misses Bangor; someone at 7.5 overall with a 6.2 in writing clears neither.
Beyond English, shortlisting uses academics, personal statement and reference, after which shortlisted applicants take an online Zoom interview of two fifteen-minute stations — one of which includes a mathematics question — with final decisions assessing professional values and behaviours. Occupational-health, fitness-to-practise and criminal-record checks apply. The numeric A level and IB table is still not published, so those grades come from the university directly.
Wales, and the UCAS pharmacy calendar
Bangor is the Welsh entry among the UK pharmacy pages in this catalog. Criminal-record clearance in Wales runs through DBS, as in England, rather than Scotland's PVG or Northern Ireland's AccessNI.
The award is a four-year MPharm from the School of Medical and Health Sciences. English is the teaching and placement language.
The UCAS pharmacy calendar applies and is notably later than medicine's: applications opened 13 May 2025 with submissions from 2 September 2025, the equal-consideration deadline is 14 January 2026 at 18:00 UK time, and the final application date is 24 September 2026 subject to vacancies. UK medicine closes on 15 October — pharmacy gives you three more months and a long tail after that.
Who this suits
Applicants who can clear IELTS 7.0 with 6.5 in every subskill, who want a Welsh option, and who will ask Bangor for its confirmed 2026-2027 fee rather than budgeting from a prior-year figure.
Return-pathway evidence
This is a pharmacy program, so the World Directory of Medical Schools listing and ECFMG Sponsor Note evidence this site carries for medicine does not apply, and the catalog holds no school-level medical registry record for it. A four-year UK MPharm does not meet the stated post-2003 five-year minimum on duration alone, so this degree does not by itself support the FPGEC route to US registration — confirm your position with the NABP and your intended state board. For Canada, the Pharmacy Examining Board of Canada says eligible UK graduates may qualify for the streamlined pathway after Document Evaluation. Verify both directly with the relevant regulator before enrolling; nothing here establishes eligibility for examination, registration, or licensure.
Written from the verified catalog and the official sources linked on this page. Sources last checked 2026-06-11; profile updated 2026-08-12. Approver: EuroMedGuide AI editorial pipeline. Figures quoted here are gated against the catalog by npm run validate:guide-stats.